Patient Protection and Affordable Care Act

Patient Protection and Affordable Care Act (PPACA)

H. R. 3590-686: Patient Protection and Affordable Care Act (PPACA) in PDF

One Hundred Eleventh Congress of the United States of America AT THE SECOND SESSION Begun and held at the City of Washington on Tuesday, the fifth day of January, two thousand and ten

An Act

Entitled The Patient Protection and Affordable Care Act. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE; TABLE OF CONTENTS.

(a) SHORT TITLE.—This Act may be cited as the ‘‘Patient Protection and Affordable Care Act’’.

Biologics Price Competition and Innovation Act of 2009 (“BPCIA”)

H. R. 3590-686

LICENSURE OF BIOLOGICAL PRODUCTS AS BIOSIMILAR OR INTERCHANGEABLE.—Section 351 of the Public Health Service Act (PHSA) (42 U.S.C. 262)

Federal Food, Drug, and Cosmetic Act (FD&C Act of 1938; FFDCA, FDCA or the Act)

[As Amended Through P.L. 113–5, Enacted March 13, 2013]

You may register and download the following statutes.   The FD&C Act consists of 692 pages (as amended on April 24, 2013).

FEDERAL FOOD, DRUG, AND COSMETIC ACT (FD & C Act or the Act) [As Amended Through P.L. 113–5, Enacted March 13, 2013]

  • CHAPTER I—SHORT TITLE
  • CHAPTER II—DEFINITIONS
  • CHAPTER III—PROHIBITED ACTS AND PENALTIES
  • CHAPTER IV—FOOD
  • CHAPTER V—DRUGS AND DEVICES
  • CHAPTER VII: GENERAL AUTHORITY
  • CHAPTER IX: TOBACCO PRODUCTS
  • SUBCHAPTER IX – TOBACCO PRODUCTS
  • CHAPTER X: MISCELLANEOUS

Download FD&C Act in PDF here >>

Food and Drug Administration Safety and Innovation Act (FDASIA) of 2012

To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes.

Last Updated: 2020-06-07